Gainers
- Zentek Ltd. (NASDAQ:ZTEK) rose 180.5% to $7.63 in pre-market trading after declining around 5% on Tuesday.
- Creative Realities Inc (NASDAQ:CREX) shares rose 52.6% to $1.31 in pre-market trading after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance.
- Allego NV (NYSE:ALLG) rose 30.3% to $10.79 in pre-market trading.
- 4D pharma (NASDAQ:LBPS) rose 26% to $5.88 in pre-market trading after jumping more than 7% on Tuesday.
- Hycroft Mining Holding Corporation (NASDAQ:HYMC) rose 20.5% to $1.58 in pre-market trading after climbing around 6% on Tuesday.
- Femasys Inc (NASDAQ:FEMY) rose 18% to $2.23 in pre-market trading. Femasys recently named Dov Elefant to new position of Chief Financial Officer.
- ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares rose 15.3% to $0.6489 in pre-market trading after dropping around 12% on Tuesday.
- Stealth BioTherapeutics Corp (NASDAQ:MITO) rose 15.3% to $0.7705 in pre-market trading. Stealth BioTherapeutics recently presented new data demonstrating the potential synergistic relationship between elamipretide and an exon-skipping phosphorodiamidate morpholino oligomer (PMO) in the X-linked muscular dystrophy (mdx) animal model.
- Koss Corporation (NASDAQ:KOSS) rose 14% to $10.97 in pre-market trading after jumping around 30% on Tuesday.
- Inpixon (NASDAQ:INPX) rose 13.4% to $0.3544 in pre-market trading. Inpixon, on Tuesday, reported pricing of $50 million registered direct offering.
- HEXO Corp. (NASDAQ:HEXO) rose 12.5% to $0.6689 in pre-market trading. HEXO recentlyreported its financial results for the fiscal quarter ended January 31, 2022 (Q2’22), revealing net loss of CA$690.2 million ($546,94 million) compared to CA$20,8 million in the same period of 2021.
- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) rose 12.1% to $6.85 in pre-market trading. NeuroSense Therapeutics recently received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
